D
Doe
Guest
Schweiz Med Wochenschr. 1989 Dec 23;119(51):1862-7. Related Articles, Links
[Hemodilution in patients with multiple morbidity and
peripheral arterial occlusive disease]
[Article in German]
Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A,
Schieffer H, Wenzel
E.
Abteilung fur Klinische Hamostaseologie und
Transfusionsmedizin Universitat des Saarlandes, Homburg-
Saar, BRD.
The treatment of multi-morbid patients suffering from
peripheral arterial occlusive disease (PAOD) is rendered
difficult due to concomitant diseases such as coronary heart
disease, chronic obstructive pulmonary affection, arterial
hypertension or diabetes mellitus. Haemodilution can be a
clinically efficient therapy for some of the concomitant
diseases as well. It is, however, necessary to use a weak
colloidal solution which has no additional volume effect as
an iso-oncotic substance. Hydroxyethyl starch 200/0.5 6%
meets all these demands. In a double-blind, placebo-
controlled study over a period of 6 weeks a marked and
significant increase of almost 40% in painfree walking
distance was achieved for 19 of 37 multi-morbid patients
with PAOD II by moderate hypervolaemic haemodilution with
venesections. Besides the clinical improvement, blood
fluidity also increased through a reduction in haematocrit,
plasma viscosity, and erythrocyte aggregation.
Publication Types: Clinical Trial Controlled Clinical Trial
Randomized Controlled Trial
PMID: 2481883 [PubMed - indexed for MEDLINE]
------------------------------------------------------------
--------------
------
Who loves ya. Tom Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore DEAD
PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
[Hemodilution in patients with multiple morbidity and
peripheral arterial occlusive disease]
[Article in German]
Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A,
Schieffer H, Wenzel
E.
Abteilung fur Klinische Hamostaseologie und
Transfusionsmedizin Universitat des Saarlandes, Homburg-
Saar, BRD.
The treatment of multi-morbid patients suffering from
peripheral arterial occlusive disease (PAOD) is rendered
difficult due to concomitant diseases such as coronary heart
disease, chronic obstructive pulmonary affection, arterial
hypertension or diabetes mellitus. Haemodilution can be a
clinically efficient therapy for some of the concomitant
diseases as well. It is, however, necessary to use a weak
colloidal solution which has no additional volume effect as
an iso-oncotic substance. Hydroxyethyl starch 200/0.5 6%
meets all these demands. In a double-blind, placebo-
controlled study over a period of 6 weeks a marked and
significant increase of almost 40% in painfree walking
distance was achieved for 19 of 37 multi-morbid patients
with PAOD II by moderate hypervolaemic haemodilution with
venesections. Besides the clinical improvement, blood
fluidity also increased through a reduction in haematocrit,
plasma viscosity, and erythrocyte aggregation.
Publication Types: Clinical Trial Controlled Clinical Trial
Randomized Controlled Trial
PMID: 2481883 [PubMed - indexed for MEDLINE]
------------------------------------------------------------
--------------
------
Who loves ya. Tom Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore DEAD
PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking